Patterns of drug resistance in pulmonary tuberculosis cases in the Izmir district, Turkey

New Microbiologica

Volumn 32, Issue 1, 2009, Pages 31-37

  Tatar, Dursun ^a   Senol, Gunes ^a,b   Cosar, Didem ^a   Ozacar, Rifat ^a   Halilcolar, Huseyin ^a  

^a Dr Suat Seren Training and Research Hospital for Chest Diseases and Chest Surgery   (Turkey)

^b NONE   (Turkey)

Author keywords

Drug resistance; Drug resistance pattern; New cases; Previously treated cases; Tuberculosis

Indexed keywords

TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; CHILD; DRUG EFFECT; HEALTH SURVEY; HUMAN; LUNG TUBERCULOSIS; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; MULTIDRUG RESISTANCE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; TURKEY (REPUBLIC);

ADOLESCENT; ADULT; ANTITUBERCULAR AGENTS; CHILD; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; POPULATION SURVEILLANCE; PREVALENCE; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; TURKEY; YOUNG ADULT;

EID: 62149146417     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. BENGISUN S., KARNAK D., PALABIYIKOGLU I., SAYGUN N. (2000). Mycobacterium tuberculosis drug resistance in Turkey, 1976-97. Scand. J. Infect. Dis. 32, 507-510.
2. CANETTI G., FOX W., KHOMENKO A., MAHLER H.T., MENON N.K., MITCHISON D.A., RIST N., SMELEV N.A. (1969). Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ 4, 21-43.
3. CAǦLAR A.S., CICEK A-M., OZKAN S., CAGLAR A. (2003). Drug resistance in pulmonary tuberculosis patients in Ankara. XXIII. National tuberculosis and Chest Diseases Congress. April 2003, Malatya, Turkey. Tuberculosis and Control of Tuberculosis Congress Book. Poster No: PS 6. Available at: http://www.verem.org.tr/pdf/PS.pdf
4. DOǦAN O.T., OZSAHIN S.L., KAYA S., BAKICI M.Z., YALDIZ A.I. (2004) Anti tuberculosis drug resistance in consecutive 385 patients followed since 1999 in Cumhuriyet University hospital. Cumhuriyet University Medicine Faculty Journal. 26, 81-84.
5. EUROTB AND THE NATIONAL COORDINATORS FOR TUBERCULOSIS SURVEILLANCE IN THE WHO EUROPEAN REGION. Surveillance of tuberculosis in Europe. Report on tuberculosis cases notified in 2003, Institute de Veille Sanitaire, Saint-Maurice, France. September 2005.
6. GÜNERI S., UNSAL I., OZTOP A., ERKUT M., AVKAN O.V., OZGU A., CAKMAK R. (2004). The resistance rates of Mycobactenum tuberculosis strains to antituberculosis drugs: evaluation of two years' data in Aegean region, Turkey. Mikrobiyol Bul. 38, 203-212.
7. KARABAY O., OTKUN M., AKATA F., KARLIKAYA C., TUGRUL M., DUNDAR V. (2004). Antituberculosis drug resistance and associated risk factors in the European section of Turkey. Indian. J. Chest Dis. Allied Sci. 46, 171-177.
8. KARTALOǦLU Z., BOZKANAT E., OZTURKERI H., OKUTAN O., ILVAN A. (2002). 365 tuberculosis cases with primary anti-tuberculosis drug resistance using the BACTEC method. Journal of Respiration 4, 443-448.
9. KOCAMIS H. (2005). Tuberculosis. In: Kocamis H, ed. Obligatory notified communicable diseases, Izmir, 1994-2004. Izmir District Ministry of Health proceedings. Soner Ofset, Izmir: 96-98.
10. LASZLO A., RAHMAN M., RAVIGLIONE M.C., BUSTREO F., THE WHO/IUATLD NETWORK OF SUPRANATIONAL REFERENCE LABORATORIES. (1997) Quality assurance programme for drug susceptibility testing of Mycobactenum tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing. Int. J. Tuberc. Lung. Dis. 1, 231-238.
11. LODDENKEMPER R., SAGEBIEL D., BRENDEL A. (2000) Strategies against multidrug-resistant tuberculosis. Eur. Respir. J. 20, 66-77.
12. MITCHISON D.A. (1984) Drug resistance in mycobacteria. Br. Med. Bull. 40, 84-90.
13. OGUL E., GÜR A., OZDEMIR A., KANMAZ D., KIRAZ R., CAMSARI G., BARCAN F. (1999). Our primary and secondary resistance rates of patients with pulmonary tuberculosis hospitalized in Yedikule Chest Hospital in 1995-1997. Respiratory Diseases. 10, 238-244.
14. OZKARA S., AKTAS Z., OZKAN S., ECEVIT H. (2003). Reference book for tuberculosis control in Turkey. (In Turkish) Ankara: 8-10. http://www.verem.org.tr/ kitap.php
15. OZSAHIN S.L., KARACAN O., EL R., GULLU Z. (2000). Drug resistance in patients following in SSK Ballidag Chest Diseases Hospital between 1995-1997. Journal of Respiratory Diseases. 11, 289-293.
16. SCHWŸBEL V., LAMBREGTS-VAN WEEZENBEEK C.S.B., MORO M.L., DROBNIEWSKI F., HOFFNER S.E., RAVIGLIONE M.C., RIEDER. H.L. (2000). Standardization of antituberculosis drug resistance surveillance in Europe. Eur. Respir. J. 16, 364-371.
17. SEVIM T., ATAÇ G., HATIPOĢLU T. (1999). Primary and secondary resistance rates of 2161 patients with pulmonary tuberculosis hospitalized in our hospi-tal 1993-1995. Respiratory Diseases. 10, 231-237.
18. TALAY F., ALTIN S., ÇETINKAYA E., KÜMBETLIS. (2003). Drug resistance rates in Istanbul Eyup TB Office in!997-2000. XXIII. National tuberculosis and Chest Diseases Congress. April 2003, Malatya, Turkey. Tuberculosis and Control of Tuberculosis Congress Book. Poster No: PS 37. Available at: http://www.verem.org.tr/pdf/PS.pdf
19. UÇAN E.S. (1994). The problem of drug resistant tuberculosis in Turkey. Tuberc and Toraks. 42, 219-226.
20. WORLD HEALTH ORGANIZATION. (2004). Anti-tuberculosis drug resistance in the world. Report No. 3. The WHO/IUATLD project on anti-tuberculosis drug resistance surveillance. Available at: www.who.int. gtb/publications/drugresistance/2004/drs_report_ex ec.pdf.
21. WORLD HEALTH ORGANIZATION (2005) Global Tuberculosis Control: Surveillance, Planning, Financing. WHO Report. Geneva, Switzerland, WHO/HTM/TB/2005.349.
22. YOLSAL N., MALAT G., DI ÇI R., ÖRKÜN M., KILIÇASLAN Z. (1998). Comparing problem of antituberculous drug resistance 1984-1989 and 1990-1995: Metaanalysis. Journal of Klimik. 11, 6-9.
23. ZWOLSKA Z., AUGUSTYNOWICZ-KOPEC E., KLATT M. (2000). Primary and acquired drug resistance in Polish tuberculosis patients: results of a study of the national drug resistance surveillance programme. Int. J. Tuberc. Lung. Dis. 4, 832-838.